ArticleTranslational cancer research2025

Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death receptor-1 inhibitors for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Yonghong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.